Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-22-014572

Options or other derivatives

  • President, CEO and Director acquired 1,704,328 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MARTELL RON · President, CEO and Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-21 Grant or award : show line 1 in the form Stock Option (right to buy) +1,704,328 1,704,328 D
Loading xslF345X03/ownership.xml…